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ABSTRACT 
Objective: The aim of the study was to design and develop a gel based drug delivery system containing combinational drugs (ketoconazole, 
neomycin sulphate and diclofenac) for the effective treatment of Paronychia. 
Methods: The drugs used are ketoconazole, neomycin sulphate and diclofenac. The first two drugs provide an antifungal and antibacterial action 
and the last drug with a pain relieving effect. Two formulations of gels F1 and F2 were prepared using polymers like carbopol 934 and xanthan gum 
respectively. The amounts of drugs and other ingredients were kept as constant in both formulations. The prepared formulations were then 
evaluated by visual examination, pH, drug content, spredability, extrudability, drug release study, in vitro antibacterial study, in vitro antifungal 
study, stability studies and in vivo antibacterial study. 
Results: The obtained results were analyzed and compared. All the test results were within the accepted limit. The physicochemical properties of 
the gels were assessed and it was found that the two formulations have enough gel consistency with good spreadability and extrudability. The drug 
content and drug release studies of the prepared gels were done and the results showed that the all the three drugs were properly loaded into the 
gel system, with good drug release profile. The antimicrobial activities of the formulated gels were proved by both in vitro antifungal and 
antibacterial studies. The in vivo antibacterial studies revealed a significant reduction in bacterial count in wistar rats treated with prepared gel 
when compared with standard drug solution. From among all the developed formulations, F1 formulation with carbopol 934 has got a slight 
superior property when compared with formulation F2 xanthan gum as gelling agent.  
Conclusion: On the basis of the evaluation studies it was concluded that the drugs (ketoconazole, neomycin sulphate and diclofenac) were 
successfully incorporated into the different topical gel preparations with good physicochemical properties and antimicrobial activity. Therefore, it 
was concluded that our formulae could be very promising topical alternative for the treatment of Paronychia. 
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Nowadays different methods like spreading, rubbing, spraying, 
instillation are used as various mechanisms for topical 
preparations; it can be applied directly to the body [1]. Topical 
route is one of the most effective routes of drug administration for 
treating the skin disorders and they can enhance drug delivery 
through systemically and non-systemically [2]. The structure of 
nail consists of nail matrix, nail plate, nail bed, cuticle, nail folds 
[3] (fig. 1). The nail bed contains two portions (germinal matrix 
and sterile matrix), which are involved in production, migration 
and maintenance of nail [4]. 
 
 
Fig. 1: Longitudinal section of nail [22] 
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Paronychia is a type of inflammatory disease, occurs in tissues 
surrounding of the nail plate. It is a most affected infection of the 
hand. Paronychia is mainly two types acute and chronic. Acute 
Paronychia is mainly seen in people who bite their nails, long nails 
or occurs in manicures. The disease etiology is that this type 
infection will break the soft tissue seal on dorsal periphery of the 
nail, they will enter and forming colonies after formation of abscess 
occurs by the offending organism. The disease starts in the lateral 
nail folds and it will spread other parts, Staphylococcus aureus is the 
disease causing organism [4, 5]. 
Chronic Paronychia is persistent type infection, disease affected 
mainly in the eponchyium, it is somewhat different from acute 
Paronychia. The Paronychia is mainly seen in people they are 
chronically exposed to water, alkali etc. The etiology is similar like 
acute Paronchyia. It is caused by bacterial infection; continue by 
super infection and colony formation of eponchyium with a fungus 
such as Candida albicans. The symptoms or signs of chronic 
Paronychyia are the characteristics of longitudinal grooves on the 
surface of the nail plate, followed by long term damage to the 
germinal tissues in the eponychium [4, 5]. The acute and chronic 
Paronychia affected fingers is represented in fig. 2. 
 
 
Fig. 2: Acute and chronic paronychia affected fingers [4] 
 
Surgical treatment is another approach towards Paranochyia [6]. 
Currently there are no marketed formulations are available in the 
market to treat Paranochyia. Gel is a semisolid system contains two 
phases, a gelling agent and a liquid. Topical formulations have lot of 
application than other routes, like they will attain local action, 
percutaneous penetration of the medicament or they having an 
emollient as well as protective action. The drug inside the gel has the 
ability to penetrate the skin and provide action at the site [7]. 
Due to the non availability of a suitable dosage form to treat 
Paronychia and the difficulty in assessing the causative agent 
(bacteria, fungus or both) in the beginning of infection has lead to 
develop gel based drug delivery system containing combinational 
drugs for the effective treatment of Paronychia. The drugs used are 
ketoconazole, neomycin sulphate and diclofenac. The first two drugs 
provide an antifungal and antibacterial action and the last drug with 
a pain relieving effect. As Paronychia causes a nail piercing pain and 
the causative agents cannot be detected in the beginning the 
prepared gel system will be helpful in treating the people with 
Paronychia. 
MATERIALS AND METHODS 
Materials 
Ketoconazole, neomycin sulphate and diclofenac were obtained as a 
gift samples from IPCA laboratories Ltd, Mumbai (India). Carbopol 
934 and xanthan gum were from Sance pharmaceuticals, Kerala 
(India). Methyl paraben, propylene glycol and other reagents were 
of the Pharmacopoeial grade. 
Preparation of standard graphs of ketoconazole, neomycin and 
diclofenac  
100 mg of ketoconazole was dissolved in water and the absorbances of 
diluted concentrations were measured out in UV at 660 nm. The same 
method was followed for both neomycin and diclofenac but the 
absorbance was determined at 277 nm and 276 nm respectively [8, 26]. 
Compatibility study by FTIR  
In order to study the drug compatibility in the formulations, FTIR 
spectrum of drugs with polymers were taken. It was done by KBr pellet 
method using FTIR. FTIR spectra of ketoconazole, neomycin, 
ketocinazole+neomycin, carbopol 934, xanthan gum, carbopol 934+ 
ketoconazole, carbopol 934+neomycin, xanthan gum+ketoconazole and 
xanthan gum+neomycin were taken [8]. 
Solubility 
Solubility study was done using different solvent system such as 
water, ethanol and phosphate buffer (pH 5.5 and 7.4) [9]. 
Formulation study 
Working formula was for a quantity of 10 g of gel. Initially 0.5 g of 
carbopol 934 was taken in a beaker and dispersed with sufficient 
quantity of water using glass rod. Then it was allowed to get hydrate. 
After that it was neutralized with triethanolamine. Then accurate 
amount of drug was added with gentle stirring and the desired gel 
was formed [1]. In the second formulation (F2), 0.5 g of xanthan gum 
was replaced with 0.5 g carbopol 934. The final weight of the 
formulation was maintained as 10 g [10]. Working formula for 
formulation of gel is depicted in table 1. 
 
Table 1: Working formula for formulation of gel 
S. No. Ingredients F F1 2 
1 Ketoconazole 0.4 g 0.4 g 
2 Neomycin sulphate 0.1 g 0.1 g 
3 Diclofenac 0.2 g 0.2 g 
4 Carbopol 934 0.5 g  
5 Xanthan gum  0.5 g 
6 Propylene glycol 4 ml 4 ml 
7 Glycerin 2 ml 2 ml 
8 Triethanolamine 0.06 ml 0.06 ml 
 
Evaluation of gel 
Physiochemical parameters 
The prepared gels were evaluated for its physicochemical properties 
like clarity, colour, odour, grittiness and pH. The clarity was 
examined by visual examination against black or white background 
and the presence of gritty particles in prepared gels was tested 
microscopically. The prepared formulations were spread on a 
mounting glass plate and viewed under microscope [12]. The pH of 
the prepared gel formulations was determined by digital pH meter 
(Systronics pH meter Model 6), it was calibrated using standard 
buffer solutions at pH 4, 7 and 9 [11, 22]. 
Spreadability 
It is determined by the following method. The instrument consists of 
a wooden block, and a pulley at one end. First of all a glass was fixed 
to the wooden block using an adhesive. About 2 g was gel was placed 
on the glass. Another slide of same dimension (with a hook) was 
placed over the fixed slide and the gel got sandwiched. Almost 1 kg 
weight was placed over the slide to remove the air entrapment. Then 
a weight of 30 g is attached to the hook of the slide with a string and 
allows some time to move the top slide through the fixed slide. 
Notice the time (in s) taken up by the top slide to cover a distance of 
4.6 cm. A shorter interval indicates better spreadability [13]. 
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Spreadability, )( TLMS ÷=  
S = SpreadabilityM = Weight in pan 
L = Length moved by the glass slideT = time taken to separate the 
slides 
Extrudability study 
This method was used to analyze the force required to squeeze the 
content out of the tube. aluminium collapsible tube filled with 10 g 
gels was compressed and extrudability of the formulation was 
determined in terms of weight in grams required to extrude a 0.5 cm 
ribbon of gel in 10 s [14]. 
Drug content determination 
The gel having a weight of 500 mg was weighed and solubilized in 
50 ml of phosphate buffer solution (PBS) pH 5.5 and shakes well to 
extract the drug and filtered. The drug content was analysed 
spectrophotometrically (ketoconazole 660 nm, neomycin 277 nm, 
diclofenac 276 nm) [15]. 
In vitro drug release study 
The study was done using Franz diffusion cell with cellophane 
membrane as barrier and 100 ml of PBS pH5.5 was used in the 
receptor compartment, then 1 g of gel (expected to contain 40 mg of 
ketoconazole, 10 mg neomycin and 20 mg of diclofenac) was spread 
uniformly on the membrane. The drug concentration on the receptor 
fluid was determined spectrophotometrically (ketoconazole 660 nm, 
keomycin 277 nm, diclofenac 276 nm) against appropriate blank 
(sampling Time 0, 5, 10, 15, 30, 60, 120 min). The experiment was 
carried out in triplicate [16]. 
In vitro antibacterial study 
An agar-well diffusion method was used for determination of 
antibacterial activity of neomycin sulphate. The gel samples were 
dissolved in PBS, pH5.5. The cultured bacteria (Staphylococcus 
aureus) were suspended in sterile water and diluted to 10 colony 
found per unit (CFU)/ml. The suspension (100 μl) was spread onto 
the surface of nutrient agar medium. Wells (4.6 mm in diameter) 
were cut with a sterile borer and 60 μl formulations were added into 
them. PBS solution was used as negative control. Incubation of the 
inoculated plates was done at 37 °C for 24 h. The diameter of 
inhibition zone (DIZ) was evaluated and thereby antibacterial 
activity also. All tests were performed in triplicates [17, 23]. 
In vitro antifungal study 
The antifungal activity of ketoconazole was done by agar-well 
diffusion method, in which the Candida albicans was inoculated with 
molten potato dextrose agar at 45 °C and allowed to set in a petri 
dish. Wells (4.6 mm in diameter) were cut in a similar way as for the 
antibacterial activity and 60 μl formulations were added into them. 
PBS was used to prepare the negative control. The plates were 
incubated at 28 °C for 3 d after which DIZ were measured [18]. 
Stability study 
The prepared formulations (F1 and F2) were maintained at room 
temperature over a period of two months in three types of storage 
containers (plastic transparent, glass transparent and collapsible 
metallic tubes). The physical appearance, homogeneity, syneresis 
and drug contents were evaluated after 2 mo [19]. The experiments 
were performed in triplicates. 
Optimization of gels 
The prepared gels were optimized by using the evaluated data. All 
the test parameters were taken into account [20]. 
In vivo antibacterial study 
The study was conducted at central animal house, Amrita Institute of 
Medical Science, Kochi. All the experimental procedures were 
approved (IAEC/2017/3/11) and performed in accordance with the 
standards prescribed by the institutional animal ethical committee. 
12 adult male rats of Wistar strain with body weighing 300 to 350 g, 
maintained under controlled light and temperature were used in 
this study. The animals were caged (one animal per cage) with 
standard food and water ad libitum. The animals were grouped into 
three, Group 1: F1 formulation Group 2: neomycin solution and 
Group 3: control (water for injection). Staphylococcus aureus 
bacteria were obtained from microbiology lab, Amrita School of 
Pharmacy and were used in this study. The anesthetized animals 
were placed in prone position, and it was sterilized with alcohol-
iodine. A punch was used to achieve the wounds of approximately 8 
mm diameter allowing the removal of a circular area of skin, on the 
middle portion of the medium sagittal plane. After its preparation, 
the wounds were colonized with a standard solution of 
Staphylococcus aureus and quantitation of bacterial population was 
done. Then, the 3 groups were applied with equal aliquots of F1 
formulation, neomycin solution and water for injection respectively. 
Each group of mice receiving a particular treatment regimen was 
housed separately in a ventilated cage with appropriate bedding, 
food, and water. Mice were checked twice daily during infection and 
treatment to ensure no adverse reactions were observed. After 48 h, 
exudates were collected from the wounds for quantitation of bacterial 
population. The materials were processed and cultured on selective 
MacConkey’s agar medium. The agar plates were incubated at 37 °C 
and examined after 24 h. Any growth in the plates of bacteria of the 
same biotype as cultured in the wounds was considered positive and 
expressed as colony forming units per gram of tissue [21]. 
RESULTS AND DISCUSSION 
Absorbance values of ketoconazole, neomycin and diclofenac are 
shown in (table 2) and standard graphs were plotted between 
concentrations on X axis, absorbance on Y axis (fig. 3). 
The FTIR analysis (fig. 4, fig. 5 and fig. 6) showed that there are no 
incompatibilities in the formulation. All the identification peaks of 
drugs are existing in the formulation also. The identification peaks of 
ketoconazole are C=O Stretching vibration of carbonyl group–1653 
cmˉ1, C-O stretching of aliphatic ether groups–1031.92 cm̄ 1, C-O 
stretching of cyclic ether–1271 cm̄ 1 and chlorine group-727 cm̄ 1. 
The identification peaks of neomycin OH stretching-3500 cmˉ1, N-H 
bending-1666 cmˉ1 and ether frequency-1180 cmˉ1
Solubility study was done using different solvent system. The 
obtained result was shown in (table 4) 
. So FTIR analysis 
revealed that the drug combinations are compatible and stable with 
other drugs and gelling agents [10, 11, 25]. 
Solubility 
 












At 276 nm 
0 0 0 0 0 0 
0.25 0.142 0.10 0.006 10 0.112 
0.3 0.286 0.20 0.013 20 0.223 
0.35 0.431 0.30 0.019 30 0.32 
0.4 0.569 0.40 0.025 40 0.441 
0.45 0.723 0.50 0.033 50 0.545 
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Fig. 3: Standard graphs of ketoconazole, neomycin, diclofenac compatibility study by FTIR 
 
 
Fig. 4: FTIR spectra of A) Ketoconazole, B) Neomycin, C)Ketoconazole+neomycin and D) carbopol 934 
 
 
Fig. 5: FTIR spectra of A) Xanthan Gum, B) Carbopol 934+Ketoconazole, C) Carbopol 934+Neomycin and D) Xanthan Gum+Ketoconazole 
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Fig. 6: FTIR spectrum of xanthan gum+neomycin 
 
Table 3: Solubility profile of ketoconazole, neomycin and diclofenac in different solvents 
Drug Solubility in solvents 
Water Ethanol Phosphate buffer (pH 5.5 and 7.4) 
Ketoconazole Soluble Soluble Soluble 
Neomycin Soluble Insoluble Soluble 
Diclofenac Soluble Soluble Soluble 
(n=3)    
 
 
Fig. 7: The prepared gels F1 (carbopol 934) and F2 (xanthan gum) as gelling agents 
 
Formulation study 
The formulations of gels were prepared as prescribed method and it 
is shown in (fig. 7). 
Physiochemical parameters 
The prepared formulations were evaluated for clarity test and the 
study results show that, both the gels were clear and free of 
particles. The formulations exhibited a good homogeneity. The gel 
with carbopol 934 as gelling agent showed a good transparency 
when compared with the gel with xanthan gum as gelling agent. 
Both the formulations were viscous in nature. Xanthan gum 
showed a translucent nature. The formulated gels were visually 
evaluated and it was found to be clear and white cloudy 
appearance for gel with carbopol 934 as gelling agent whereas the 
other formulation appeared as slight yellowish color with good 
clarity. Both the formulations have got a rose fragrance. The 
samples were free of particulate matter was seen under light 
microscope. Hence the gel is free of particular matter and can be 
used for any topical preparation. The pH of the formulated gels 
was found to be 5.7±0.1 for carbopol 934 gel and 6.4±0.1 for 
xanthan gum gel. The obtained pH resembles to skin pH and 
compatable for topical formulation [10, 12, 15]. Physicochemical 
properties of the gels are summarized in table 4. 
 
Table 4: Physicochemical properties of the gels 
Topical gels Color Homogenity pH Odour 
F Transparent 1 Homogenous 5.7±0.1 Rose fragrance 
F Translucent yellowish 2 Homogenous 6.4±0.1 Rose fragrance 
Data expressed as mean±SD (n=3) 
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Spreadability and extrudability study 
The spreadability test was performed as prescribed in the 
procedure. The test results revealed that the gel with carbopol 934 
as gelling agent has got a higher spreadability when compared 
with xanthan gum gel formulation. The values of spreadability 
were 4.6 cm and 4.2 cm respectively for both carbopol 934 and 
xanthan gum gels [18, 20]. The slight change in spreadability may 
be due to the change in polymer. All the two formulations showed 
a good extrudability. There is no significance change in the 
extrudabilities of F1 and F2. So, plug flow is limited in this 
formulation and is easy to squeeze out the formulation from the 
collapsible tube and there is a uniformity of drug contents in the 
extruded mass [20]. 
Drug content determination 
Results of drug content are shown in (table 5). After the formulation 
of the two types of gels, the drug content of the formulated gel was 
estimated and the results were in the official limits. The drug 
content determination also showed the uniformity of drug 
distribution in the gel [18, 20]. 
 
Table 5: Drug content of the gels 
Topical gels Ketoconazole Neomycin Diclofenac 
%W/W % W/W % W/W 
F 98.4±0.7 1 97.4±1.1 99.2±0.8 
F 98.0±1.0 2 96.0±0.9 98.6±1.0 
*Data expressed as mean±SD (n=3) 
 
In vitro drug release study 
It was observed that the release of the drugs from its different 
formulae didn’t show any significant difference in drug release. .On 
comparison of the obtained in vitro data; it was found that F1 
showed a bit faster release of drugs when compared with F2. The 
amount of the drug released after 2 h were 40.1±1.22%, 
40.1±1.24%, and 53±1.24% for ketoconazole, neomycin and 
diclofenac respectively from F1, whereas in F2 the release was 
38±1.27%, 38±1.20% and 52±1.27% respectively.  
On analysis, it was found that almost 30% of the drug is been 
released within 5 min. So it is an indication that the gel will act very 
fast in the infected area. Especially the drug release for diclofenac 
was almost 40% within 5 min and may get a faster pain relieving 
action in the affected area. It is shown in (table 6). 
 
Table 6: In vitro drug release profile 
Time (min) F1 F2 
K1 N1 D1 K2 N2 D2 
0 0 0 0 0 0 0 
5 31.0±1.25 30.0±1.22 41.5±1.21 29.0±1.22 28.0±1.24 38.0±1.20 
10 32.2±1.20 32.5±1.25 42.5±1.22 30.2±1.25 29.2±1.25 39.2±1.22 
15 33.4±1.21 33.7±1.20 45.5±1.20 31.4±1.28 30.4±1.22 40.4±1.24 
30 35.0±1.22 36.5±1.27 48.5±1.25 33.9±1.24 32.4±1.24 44.0±1.28 
60 38.5±1.20 38.0±1.22 51.0±1.24 36.0±1.27 35.5±1.27 48.0±1.25 
120 40.1±1.22 40.1±1.24 53.0±1.24 38.0±1.27 38.0±1.20 52.0±1.27 
 *Data expressed as mean±SD (n=3) K-ketoconazole, N-neomycin and D-diclofenac 
 
In vitro antibacterial and antifungal study 
The antibacterial activities of neomycin from its different gel 
formulae were compared. The results were satisfactory. In this case 
the DIZ was same (33±1 mm) for both F1 and F2. The results of all 
formulae were satisfactory for antifungal study also. A slight 
increased activity was observed with F1 where the inhibition zone 
reaches 37±1 mm whereas F2 where the inhibition was 35±1 mm 
[17, 18]. There is not much significant difference in antifungal 
activity of ketoconazole in both the formulations. 
Stability study 
On evaluation of the formulations, it was found that there is some 
slight change in the physical characters of the formulations (F1and 
F2) that stored in plastic container when compared with other 
containers. It is shown in (table 7). The formulations stored in 
plastic containers showed a red coloration; it may be due to the 
leaching of the container. The formulations in other containers were 
found to be stable with no coloration. Other physical parameters 
were same for all the formulations during the entire storage period. 
There were no syneresis and grittiness in all the stored formulations 
[19]. The drug content results revealed that there is no significant 
change in drug content after stability study. 
Optimization of gel 
The optimization of the prepared gels was done by comparing the 
results of different evaluation tests. By comparing all the data it was 
found that the F1 formulation with carbopol 934 as gelling has got a 
slight superior property when compared with F2; where xanthan 
gum was used as gelling agent. The change in evaluation test results 
may be mainly due to the change in polymer. 
 
Table 7: Stability data of F1 and F2 formulations after two months (K-ketoconazole) 
Formulation Container Physical Parameters Syneresis Drug content, K 
Color Homogeneity Odour Grittiness 
F1 Plastic Red Homogeneous Rose No No 98.0±0.1% 
F2 Plastic Red Homogeneous Rose No No 96.5±0.5% 
F1 Glass White transparent Homogeneous Rose No No 98.1±0.8% 
F2 Glass Yellowish translucent Homogeneous Rose No No 97.2±0.5% 
F1 C. Tube White transparent Homogeneous Rose No No 98.5±0.4% 
F2 C. Tube Yellowish translucent Homogeneous Rose No No 98±0.6% 
*Data expressed as mean±SD (n=3), K-Ketoconazole 
Mohanan et al. 
Int J App Pharm, Vol 10, Issue 6, 2018, 161-167 
 
167 
In vivo antibacterial study 
The change in colony forming units for each group was investigated 
and expressed as mean values. Comparison of the values of CFU 
between the start and end times for each group were calculated 
(table 8). The values were calculated in terms of % variation in CFU 
in each group also. From the results, it was found that there is so 
much reduction in the CFU in the case of group 1 (92.38%) and 
group 2 (95.76%), which were treated with F1 formulation and 
neomycin solution respectively whereas in Group 3, a sharp increase 
in CFU was found. At the same time there is no significant difference 
in reduction in the CFU between Group 1 and 2. However in group 3 
treated with distilled water showed a 68% increment in CFU. The 
study reveals that the Formulation 1 has significant antibacterial 
action in reducing the Staphylococcus aureus and can be used in the 
treatment of Paronychia. In accordance with the presented results, it 
can conclude that Formulation 1 can be an alternative for current 
treatment and surgical method [21, 23]. 
 
Table 8: Comparison of the values of CFU between the start and end times for each group 
Animal number Group 1 Group 2 Group 3 
Start End Start End Start End 
1 2555 230 2600 108 2503 4800 
2 2203 200 3033 55 2700 4900 
3 2400 150 2879 230 2400 3300 
4 2144 130 3100 100 2452 3900 
Mean 2325.5±118.1 177.5±45.7 2903±222.1 123.5±74.8 2513.8±131.0 4225±763.2 
*Data expressed as mean±SD (n=4) 
 
CONCLUSION 
On the basis of the evaluation studies we can conclude that the drugs 
(ketoconazole, neomycin and diclofenac) were successfully 
incorporated into the different topical gel preparations. From among 
all the developed formulation, the formula F1 (carbopol 934 as gelling 
agent) showed comparatively good spreadability, extrudability, drug 
content, drug release and antimicrobial effect. But there is not much 
significant difference in the evaluated parameters of both 
formulations. The antifungal and antibacterial effects of these 
formulations also found to be satisfactory. Therefore, it was concluded 
that our formulae could be very promising topical alternative for the 
treatment of Paronychia. However, further preclinical and clinical 
studies are required to prove its application in human. 
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